Hit Identification of a Novel Dual Binder for h‐telo/c‐myc G‐Quadruplex by a Combination of Pharmacophore Structure‐Based Virtual Screening and Docking Refinement

It is well known that G‐quadruplexes are targets of great interest for their roles in crucial biological processes, such as aging and cancer. Hence, a promising strategy for anticancer drug therapy is the stabilization of these structures by small molecules. We report a high‐throughput in silico screening of commercial libraries from several different vendors by means of a combined structure‐based pharmacophore model approach followed by docking simulations. The compounds selected by the virtual screening procedure were then tested for their ability to interact with human telomeric G‐quadruplex folding by circular dichroism, fluorescence spectroscopy, and fluorescence intercalator displacement. Our approach resulted in the identification of a 13‐[(dimethylamino)methyl]‐12‐hydroxy‐8H‐benzo[c]indolo[3,2,1‐ij][1,5]naphthyridin‐8‐one derivative as a novel promising stabilizer of G‐quadruplex structures within the human telomeric and the c‐myc promoter sequences.

[1]  Peter Willett,et al.  A Screen Set Generation Algorithm , 1979, J. Chem. Inf. Comput. Sci..

[2]  G. Chang,et al.  Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .

[3]  W. C. Still,et al.  Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .

[4]  David M. Prescott,et al.  Inhibition of telomerase by G-quartet DMA structures , 1991, Nature.

[5]  D. Patel,et al.  Guanine residues in d(T2AG3) and d(T2G4) form parallel-stranded potassium cation stabilized G-quadruplexes with anti glycosidic torsion angles in solution. , 1992, Biochemistry.

[6]  W. Clark Still,et al.  AMBER torsional parameters for the peptide backbone , 1992 .

[7]  D. Patel,et al.  Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. , 1993, Structure.

[8]  S. Neidle,et al.  Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.

[9]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[10]  O. Fedoroff,et al.  NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. , 1998, Biochemistry.

[11]  K. Zeller,et al.  Function of the c-Myc oncogenic transcription factor. , 1999, Experimental cell research.

[12]  W L Jorgensen,et al.  Prediction of drug solubility from Monte Carlo simulations. , 2000, Bioorganic & medicinal chemistry letters.

[13]  L. Hurley,et al.  G-quadruplex DNA: a potential target for anti-cancer drug design. , 2000, Trends in pharmacological sciences.

[14]  K. Shin‐ya,et al.  Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. , 2001, Journal of the American Chemical Society.

[15]  J. Mergny,et al.  Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Stevens,et al.  Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. , 2001, Molecular pharmacology.

[17]  Kazuo Shin-Ya,et al.  Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. , 2002, Journal of the American Chemical Society.

[18]  D. Bearss,et al.  Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Stephen Neidle,et al.  Crystal structure of parallel quadruplexes from human telomeric DNA , 2002, Nature.

[20]  M. Searle,et al.  Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat. , 2003, Journal of Molecular Biology.

[21]  Stephen Neidle,et al.  Structure of a G-quadruplex-ligand complex. , 2003, Journal of molecular biology.

[22]  A. Phan,et al.  Two-repeat human telomeric d(TAGGGTTAGGGT) sequence forms interconverting parallel and antiparallel G-quadruplexes in solution: distinct topologies, thermodynamic properties, and folding/unfolding kinetics. , 2003, Journal of the American Chemical Society.

[23]  Paul Watson,et al.  Virtual Screening Using Protein-Ligand Docking: Avoiding Artificial Enrichment , 2004, J. Chem. Inf. Model..

[24]  Tingjun Hou,et al.  Recent development and application of virtual screening in drug discovery: an overview. , 2004, Current pharmaceutical design.

[25]  Jérôme Hert,et al.  Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures , 2004, J. Chem. Inf. Model..

[26]  Thierry Langer,et al.  Comparative Analysis of Protein-Bound Ligand Conformations with Respect to Catalyst's Conformational Space Subsampling Algorithms , 2005, J. Chem. Inf. Model..

[27]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[28]  Stephen Neidle,et al.  The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. , 2005, Cancer research.

[29]  Thierry Langer,et al.  LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..

[30]  A. Phan,et al.  Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter , 2005, Nature chemical biology.

[31]  Thierry Langer,et al.  Pharmacophore Modeling and in Silico Screening for New P450 19 (Aromatase) Inhibitors , 2006, J. Chem. Inf. Model..

[32]  U. Klotz,et al.  Biopharmaceutical Characterization of the Telomerase Inhibitor BRACO19 , 2006, Pharmaceutical Research.

[33]  Thierry Langer,et al.  High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening , 2007, J. Comput. Aided Mol. Des..

[34]  Sarah W. Burge,et al.  Quadruplex DNA: sequence, topology and structure , 2006, Nucleic acids research.

[35]  Roger A. Jones,et al.  Structure of the Hybrid-2 type intramolecular human telomeric G-quadruplex in K+ solution: insights into structure polymorphism of the human telomeric sequence , 2007, Nucleic acids research.

[36]  Roger A. Jones,et al.  Structure of the intramolecular human telomeric G-quadruplex in potassium solution: a novel adenine triple formation , 2007, Nucleic acids research.

[37]  A. Chan,et al.  Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives. , 2007, Journal of medicinal chemistry.

[38]  J. Mergny,et al.  G‐Quadruplex Recognition by Quinacridines: a SAR, NMR, and Biological Study , 2007, ChemMedChem.

[39]  A. Phan,et al.  Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution† , 2007, Nucleic acids research.

[40]  S. Alcaro,et al.  Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold. , 2007, Bioorganic & medicinal chemistry letters.

[41]  R. Gartenhaus,et al.  Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism , 2007, British Journal of Cancer.

[42]  Stephen Neidle,et al.  Structural basis of DNA quadruplex recognition by an acridine drug. , 2008, Journal of the American Chemical Society.

[43]  J. Huppert,et al.  Hunting G-quadruplexes. , 2008, Biochimie.

[44]  Jean-Louis Mergny,et al.  Targeting telomeres and telomerase. , 2008, Biochimie.

[45]  Jóhannes Reynisson,et al.  Benchmarking the reliability of QikProp. Correlation between experimental and predicted values , 2008 .

[46]  A. Lane,et al.  Stability and kinetics of G-quadruplex structures , 2008, Nucleic acids research.

[47]  G. Parkinson,et al.  Topology conservation and loop flexibility in quadruplex-drug recognition: crystal structures of inter- and intramolecular telomeric DNA quadruplex-drug complexes. , 2008, Journal of molecular biology.

[48]  Simona Distinto,et al.  Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes? , 2008, J. Comput. Aided Mol. Des..

[49]  J. Shay,et al.  Targeting telomerase for cancer therapeutics , 2008, British Journal of Cancer.

[50]  Danzhou Yang,et al.  Polymorphism of human telomeric quadruplex structures. , 2008, Biochimie.

[51]  A. Morales Helguera,et al.  Prediction of telomerase inhibitory activity for acridinic derivatives based on chemical structure. , 2009, European journal of medicinal chemistry.

[52]  Varun Khanna,et al.  Physiochemical property space distribution among human metabolites, drugs and toxins , 2009, BMC Bioinformatics.

[53]  M. Franceschin.  G‐Quadruplex DNA Structures and Organic Chemistry: More than One Connection , 2009 .

[54]  Simona Distinto,et al.  How To Optimize Shape-Based Virtual Screening: Choosing the Right Query and Including Chemical Information , 2009, J. Chem. Inf. Model..

[55]  Danzhou Yang,et al.  Structural insights into G-quadruplexes: towards new anticancer drugs. , 2010, Future medicinal chemistry.

[56]  Roger A. Jones,et al.  Structure of a two-G-tetrad intramolecular G-quadruplex formed by a variant human telomeric sequence in K+ solution: insights into the interconversion of human telomeric G-quadruplex structures , 2009, Nucleic acids research.

[57]  Xiaoping Tian,et al.  Telomere and Telomerase as Targets for Cancer Therapy , 2010, Applied biochemistry and biotechnology.

[58]  A. Nicolas,et al.  Genetic instability triggered by G-quadruplex interacting Phen-DC compounds in Saccharomyces cerevisiae , 2010, Nucleic acids research.

[59]  Stefano Alcaro,et al.  Rational Design, Synthesis, Biophysical and Antiproliferative Evaluation of Fluorenone Derivatives with DNA G‐Quadruplex Binding Properties , 2010, ChemMedChem.

[60]  Daniela Schuster,et al.  Computer-Aided Discovery, Validation, and Mechanistic Characterization of Novel Neolignan Activators of Peroxisome Proliferator-Activated Receptor γ , 2010, Molecular Pharmacology.

[61]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[62]  G. Parkinson,et al.  A structural analysis of G-quadruplex/ligand interactions. , 2011, Biochimie.

[63]  Stefano Alcaro,et al.  Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders. , 2011, Biochimie.

[64]  B. Gatto,et al.  The evolving world of protein-G-quadruplex recognition: A medicinal chemist’s perspective , 2011, Biochimie.

[65]  Stephen Neidle,et al.  Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? , 2011, Nature Reviews Drug Discovery.

[66]  Daniela Schuster,et al.  Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation , 2011, Bioorganic & medicinal chemistry.

[67]  Stefano Alcaro,et al.  The polymorphisms of DNA G-quadruplex investigated by docking experiments with telomestatin enantiomers. , 2012, Current pharmaceutical design.

[68]  Daniela Schuster,et al.  Virtual Screening as a Strategy for the Identification of Xenobiotics Disrupting Corticosteroid Action , 2012, PloS one.

[69]  V. Tumiatti,et al.  Structure-activity relationships of novel substituted naphthalene diimides as anticancer agents. , 2012, European journal of medicinal chemistry.

[70]  Stefano Alcaro,et al.  Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures. , 2012, Organic & biomolecular chemistry.

[71]  J. Shay,et al.  Is telomerase a viable target in cancer? , 2012, Mutation research.

[72]  Dik-Lung Ma,et al.  In silico screening of quadruplex-binding ligands. , 2012, Methods.

[73]  N. Zaffaroni,et al.  G-Quadruplex Structures in the Human Genome as Novel Therapeutic Targets , 2013, Molecules.

[74]  S. Balasubramanian,et al.  Quantitative visualization of DNA G-quadruplex structures in human cells. , 2013, Nature chemistry.

[75]  S. Neidle,et al.  Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands , 2013, Molecular Pharmacology.

[76]  Federica Moraca,et al.  Toward the design of new DNA G-quadruplex ligands through rational analysis of polymorphism and binding data. , 2013, European journal of medicinal chemistry.

[77]  S. Alcaro,et al.  Molecular Recognition of Human Telomeric DNA by Phenanthroline-Based G-Quadruplex Ligands , 2013 .

[78]  Stefano Alcaro,et al.  Identification and characterization of new DNA G-quadruplex binders selected by a combination of ligand and structure-based virtual screening approaches. , 2013, Journal of medicinal chemistry.

[79]  Stefano Alcaro,et al.  Targeting unimolecular G-quadruplex nucleic acids: a new paradigm for the drug discovery? , 2014, Expert opinion on drug discovery.

[80]  A. Moye,et al.  Telomeric G-quadruplexes are a substrate and site of localization for human telomerase , 2015, Nature Communications.

[81]  N. Zaffaroni,et al.  Assessment of gene promoter G‑quadruplex binding and modulation by a naphthalene diimide derivative in tumor cells. , 2015, International journal of oncology.